We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral Opportunistic Bacteria in Multiple Sclerosis with Different Treatment Modalities.
- Authors
Z. M., Al-Saadi; F. D., Al-Aswad; N. M., Sheaheed
- Abstract
Aims Multiple sclerosis is a chronic demyelinating disease that is considered an autoimmune disorder affecting the central nervous system. This study aimed to investigate the pathogenic changes in the natural flora of the mouth in MS patient during different treatment modalities and compare them with healthy individuals. Materials & Methods: 120 patients were volunteered and divided into four groups of 30 people: 1) patients with MS taking Natalizumab or Tysabri, 2) patients with MS taking Betaferon, 3) naive MS patients without medications, 4] healthy individuals (control). The changes in oral bacteria (Staphylococcus aureus, Porphyromonas gingivalis, and Bacteroides frag ills) were investigate using real time-PCR. Finding: The prevalence of S. aureus was significantly higher in the Naive MS group (p-0.016), Betaferon group (p=0.001), and Tysabri group (p=0.0001) compared to the healthy group, as well as in Tysabri group compared to the Naive MS group (p=0.005). The prevalence of P.gingivaliswas significantly higher in the Betaferon group (p=0.002) and Tysabri group (p=0.0001) compared to the healthy group, as well as in Tysabri group compared to the Naive MS group (p= 0.020). The prevalence of B. fragilis was significantly higher in the Naive MS group (p=0.008), Betaferon group (p=0.015), and Tysabri group (p=0.008) compared to the healthy group. Conclusion: Oral bacteria are involved in MS development. Furthermore, MS patients are more susceptible to periodontal disease due to high P. gingivalis presence, and these patients need to receive extra care to prevent periodontal disease.
- Subjects
IRAN; BACTERIAL disease prevention; OPPORTUNISTIC infection prevention; THERAPEUTIC use of interferons; MULTIPLE sclerosis; COMBINATION drug therapy; ORAL health; BACTEROIDES; GRAM-negative anaerobic bacteria; COMPARATIVE studies; STAPHYLOCOCCAL diseases; DISEASE prevalence; NATALIZUMAB; POLYMERASE chain reaction; COMBINED modality therapy
- Publication
Iranian Journal of War & Public Health, 2023, Vol 15, Issue 2, p191
- ISSN
2008-2622
- Publication type
Article
- DOI
10.58209/ijwph.15.2.191